UnitedHealth Group (UNH) closed at $319.97, up 2.71% from the previous day, outperforming the S&P 500. However, the stock has dropped 13.57% in the last month, trailing the Medical sector’s 4.76% gain. Analysts project a 69.60% decrease in EPS and a 12.62% revenue increase in the upcoming earnings report.

The Zacks Consensus Estimates for UnitedHealth Group predict earnings of $16.29 per share and revenue of $447.97 billion for the fiscal year. Recent analyst revisions can indicate future stock performance. The Zacks Rank, which rates stocks from #1 (Strong Buy) to #5 (Strong Sell), shows UNH at #3 (Hold) with a 0.66% increase in EPS estimate.

UnitedHealth Group currently trades with a Forward P/E ratio of 19.13, higher than the industry average of 11.81. The PEG ratio, indicating projected earnings growth, stands at 2.03, surpassing the industry average of 1.16. The Medical – HMOs industry ranks in the bottom 18% of over 250 industries, according to Zacks Industry Rank.

Zacks Investment Research offers insights into stock performance metrics like Forward P/E ratio and PEG ratio. Stay updated on UnitedHealth Group’s stock movements and industry rankings for informed investment decisions. Download the free report for the latest recommendations from Zacks Investment Research.

Read more at Nasdaq: UnitedHealth Group (UNH) Beats Stock Market Upswing: What Investors Need to Know